VC firms sell Biosensia

The vendors include Act Venture Capital, Atlantic Bridge, Street Capital and Seroba Life Sciences. 

To date, the group has raised roughly $10m. 

Kypha is a US-based medical diagnostics company developing specialised biomarker testing solutions for precision monitoring of immune status and inflammation. The acquisition will strengthen Kypha's product commercialisation.

Company
Biosensia is based in Dublin, Ireland, and was founded by Gabriel Crean and Gareth Redmond in 2009. The company is a diagnostics platform and contract development company. Biosensia's RapiPlex is a proprietary diagnostic system designed to support CLIA-waived protocols and is capable of producing laboratory-quality quantitative and qualitative results with a disposable cartridge for up to 24 analytes in a multiplex format.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Healthcare
• Exits
• Ireland
• Trade sale